Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Jacene

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Clinical Genitourinary Cancer|April 17, 2026
LuRa: Efficacy and Safety of Radium-223 Following [<sup>177</sup>Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate CancerJabra Zarka, Ronit Juthani, Oliver Sartor, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 5, 2023
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
Blood Advances|July 24, 2025
Measurable Residual Disease Detection after CAR-T May Predict Response in Patients with Large B-cell LymphomaNira Krasnow, Katie Maurer, Catherine Jiawen Song, et al.
Hemasphere|January 30, 2023
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular LymphomaReid W Merryman, Laure Michaud, Robert Redd, et al.
Blood Advances|November 18, 2022
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantationReid W Merryman, Robert A Redd, Eleanor Taranto, et al.
The New England Journal of Medicine|January 12, 2017
Phase 3 Trial of <sup>177</sup>Lu-Dotatate for Midgut Neuroendocrine TumorsJonathan Strosberg, Ghassan El-Haddad, Edward Wolin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global InitiativeAkram Al-Ibraheem, Andrew M Scott, Ahmed Saad Abdlkadir, et al.
The Journal of Clinical Investigation|August 8, 2024
F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injuryShruti Gupta, Olivia Green-Lingren, Sudhir Bhimaniya, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Clinical Genitourinary Cancer|April 17, 2026
LuRa: Efficacy and Safety of Radium-223 Following [<sup>177</sup>Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate CancerJabra Zarka, Ronit Juthani, Oliver Sartor, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 5, 2023
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
Blood Advances|July 24, 2025
Measurable Residual Disease Detection after CAR-T May Predict Response in Patients with Large B-cell LymphomaNira Krasnow, Katie Maurer, Catherine Jiawen Song, et al.
Hemasphere|January 30, 2023
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular LymphomaReid W Merryman, Laure Michaud, Robert Redd, et al.
Blood Advances|November 18, 2022
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantationReid W Merryman, Robert A Redd, Eleanor Taranto, et al.
The New England Journal of Medicine|January 12, 2017
Phase 3 Trial of <sup>177</sup>Lu-Dotatate for Midgut Neuroendocrine TumorsJonathan Strosberg, Ghassan El-Haddad, Edward Wolin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global InitiativeAkram Al-Ibraheem, Andrew M Scott, Ahmed Saad Abdlkadir, et al.
The Journal of Clinical Investigation|August 8, 2024
F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injuryShruti Gupta, Olivia Green-Lingren, Sudhir Bhimaniya, et al.
Pageof 7